Inarigivir Demonstrates Potent Dose Dependent Anti-Viral Activity in HBV Treatment-Naive Patients: Role of HBeAg Status and Baseline HBsAg in Anti-Viral Response

Man-Fung Yuen; Magdy Elkhashab; Chi-Yi Chen; Yung Fa Chen; Carla S. Coffin; Scott K. Fung; Susan Greenbloom; Jeong Won Jang; Wen-Juei Jeng; Dong Joon Kim; Yoon Jun Kim; Won Kim; Kwan Sik Lee; Young-Suk Lim; Chun-Jen Liu; Alnoor Ramji; Radhakrishnan Iyer; Chelsea Macfarlane; Kathy Jackson; Stephen Locarnini; Nezam H. Afdhal; Henry Lik Yuen Chan; ACHIEVE-STUDY Investigators

Inarigivir Demonstrates Potent Dose Dependent Anti-Viral Activity in HBV Treatment-Naive Patients: Role of HBeAg Status and Baseline HBsAg in Anti-Viral Response

Man-Fung Yuen, Magdy Elkhashab, Chi-Yi Chen, Yung Fa Chen, Carla S. Coffin, Scott K. Fung, Susan Greenbloom, Jeong Won Jang, Wen-Juei Jeng, Dong Joon Kim, Yoon Jun Kim, Won Kim, Kwan Sik Lee, Young-Suk Lim, Chun-Jen Liu, Alnoor Ramji, Radhakrishnan Iyer, Chelsea Macfarlane, Kathy Jackson, Stephen LocarniniNezam H. Afdhal, Henry Lik Yuen Chan, ACHIEVE-STUDY Investigators

School of Medicine

Research output: Contribution to journal › Journal Article › peer-review

Original language	American English
Journal	Hepatology
Volume	68
State	Published - 2018

Cite this

Yuen, M.-F., Elkhashab, M., Chen, C.-Y., Chen, Y. F., Coffin, C. S., Fung, S. K., Greenbloom, S., Jang, J. W., Jeng, W.-J., Kim, D. J., Kim, Y. J., Kim, W., Lee, K. S., Lim, Y.-S., Liu, C.-J., Ramji, A., Iyer, R., Macfarlane, C., Jackson, K., ... Investigators, ACHIEVE.-STUDY. (2018). Inarigivir Demonstrates Potent Dose Dependent Anti-Viral Activity in HBV Treatment-Naive Patients: Role of HBeAg Status and Baseline HBsAg in Anti-Viral Response. Hepatology, 68.

@article{c3be0f29d29849699c0f7744846680fd,

title = "Inarigivir Demonstrates Potent Dose Dependent Anti-Viral Activity in HBV Treatment-Naive Patients: Role of HBeAg Status and Baseline HBsAg in Anti-Viral Response",

author = "Man-Fung Yuen and Magdy Elkhashab and Chi-Yi Chen and Chen, {Yung Fa} and Coffin, {Carla S.} and Fung, {Scott K.} and Susan Greenbloom and Jang, {Jeong Won} and Wen-Juei Jeng and Kim, {Dong Joon} and Kim, {Yoon Jun} and Won Kim and Lee, {Kwan Sik} and Young-Suk Lim and Chun-Jen Liu and Alnoor Ramji and Radhakrishnan Iyer and Chelsea Macfarlane and Kathy Jackson and Stephen Locarnini and Afdhal, {Nezam H.} and Chan, {Henry Lik Yuen} and ACHIEVE-STUDY Investigators",

year = "2018",

language = "American English",

volume = "68",

journal = "Hepatology",

issn = "0270-9139",

publisher = "Lippincott Williams and Wilkins",

}

Yuen, M-F, Elkhashab, M, Chen, C-Y, Chen, YF, Coffin, CS, Fung, SK, Greenbloom, S, Jang, JW, Jeng, W-J, Kim, DJ, Kim, YJ, Kim, W, Lee, KS, Lim, Y-S, Liu, C-J, Ramji, A, Iyer, R, Macfarlane, C, Jackson, K, Locarnini, S, Afdhal, NH, Chan, HLY & Investigators, ACHIEVE-STUDY 2018, 'Inarigivir Demonstrates Potent Dose Dependent Anti-Viral Activity in HBV Treatment-Naive Patients: Role of HBeAg Status and Baseline HBsAg in Anti-Viral Response', Hepatology, vol. 68.

TY - JOUR

T1 - Inarigivir Demonstrates Potent Dose Dependent Anti-Viral Activity in HBV Treatment-Naive Patients: Role of HBeAg Status and Baseline HBsAg in Anti-Viral Response

AU - Yuen, Man-Fung

AU - Elkhashab, Magdy

AU - Chen, Chi-Yi

AU - Chen, Yung Fa

AU - Coffin, Carla S.

AU - Fung, Scott K.

AU - Greenbloom, Susan

AU - Jang, Jeong Won

AU - Jeng, Wen-Juei

AU - Kim, Dong Joon

AU - Kim, Yoon Jun

AU - Kim, Won

AU - Lee, Kwan Sik

AU - Lim, Young-Suk

AU - Liu, Chun-Jen

AU - Ramji, Alnoor

AU - Iyer, Radhakrishnan

AU - Macfarlane, Chelsea

AU - Jackson, Kathy

AU - Locarnini, Stephen

AU - Afdhal, Nezam H.

AU - Chan, Henry Lik Yuen

AU - Investigators, ACHIEVE-STUDY

PY - 2018

Y1 - 2018

M3 - Journal Article

SN - 0270-9139

VL - 68

JO - Hepatology

JF - Hepatology

ER -